ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 11,060
-400 (-3.49%)
May 20, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 121.68 billion as of May 20, 2026. Its market cap has decreased by -25.06% in one year.
Market Cap
121.68B
Enterprise Value
96.18B
Revenue
5.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,060.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 121.68B, a decrease of -24.34%. That is a compound annual growth rate of -14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 126.08B | -36.49% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 216.48B |
| JETEMA, | 213.58B |
| Macrogen | 157.85B |
| Vaxcell-Bio Therapeutics | 149.31B |
| MedPacto | 148.24B |
| Amicogen | 117.16B |
| iNtRON Biotechnology | 99.90B |
| Prestige BioPharma | 93.51B |